Offer - Urjas Oil for just ₹ 1 X
Kefpod CV 200 Mg/125 Mg Tablet is a prescription medicine that is available as a Tablet. Other than this, Kefpod CV 200 Mg/125 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Kefpod CV 200 Mg/125 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Kefpod CV 200 Mg/125 Mg Tablet can also lead to other problems, which have been listed below. Such side effects of Kefpod CV 200 Mg/125 Mg Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Kefpod CV 200 Mg/125 Mg Tablet is Mild for pregnant women and Moderate for women who are breastfeeding. In addition, Kefpod CV 200 Mg/125 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Kefpod CV 200 Mg/125 Mg Tablet related warnings section.
Individuals suffering from medical conditions like Jaundice must refrain from the use of Kefpod CV 200 Mg/125 Mg Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Kefpod CV 200 Mg/125 Mg Tablet are listed in the contraindications section below.
Drug reaction of Kefpod CV 200 Mg/125 Mg Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Kefpod CV 200 Mg/125 Mg Tablet is considered safe while driving, and is addictive.
Kefpod CV 200 Mg/125 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Kefpod CV 200 Mg/125 Mg Tablet safe for pregnant women?
Kefpod CV has mild to no side effects in pregnant women.
Is the use of Kefpod CV 200 Mg/125 Mg Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Kefpod CV. Immediately discontinue Kefpod CV if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Kefpod CV 200 Mg/125 Mg Tablet on the Kidneys?
There may be some adverse effects on kidney after taking Kefpod CV. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Kefpod CV 200 Mg/125 Mg Tablet on the Liver?
You may experience side effects on your liver after taking Kefpod CV. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Kefpod CV 200 Mg/125 Mg Tablet on the Heart?
Kefpod CV may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Kefpod CV 200 Mg/125 Mg Tablet unless your doctor advises you to do so -
Is this Kefpod CV 200 Mg/125 Mg Tablet habit forming or addictive?
Kefpod CV 200 Mg/125 Mg Tablet does not cause addiction.
Interaction between Food and Kefpod CV 200 Mg/125 Mg Tablet
Taking Kefpod CV 200 Mg/125 Mg Tablet with food does not harm your health.
Interaction between Alcohol and Kefpod CV 200 Mg/125 Mg Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Kefpod CV 200 Mg/125 Mg Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311